Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for Prevention of Septic Shock
2007-004401-10Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sepsis and septic shock comparing Hydrocortisone with Placebo or standard care control (2 arms). Primary endpoint: Septic shock. Started Feb 2008; status: completed.
02
Drugs
hydrocortisone
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on 2007-004401-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004401-10.